The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease
A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 1600 participants.
Also called NCT01508663
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; no masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 1,600 participants
- Sponsor
- Registry
-
NCT01508663
-
- Start date
- (registry gives no type)
- Primary completion
- (anticipated)
- Completion
- Not reported
- Countries
- South Korea
- Registry status
- Unknown status
Technical summary
Registry record NCT01508663. Randomized; no masking; primary purpose treatment. Start 2010-08 (registry gives no type); primary completion 2014-02 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- The Beneficial Role of Percutaneous Coronary Intervention Over Optimal Medical Therapy in Elderly Patients With Coronary Artery Disease
- Acronym
- BRAVE
- Condition
- Coronary Artery Disease
- Intervention (Device)
- Everolimus Eluting Stent or Zotalolimus Eluting Stent
- Intervention (Drug)
- ARB, CCB, ACE-inhibitor (ACE inhibitor), statin, Nitrate, Antiplate etc.
- Lead sponsor
- Yonsei University
Record details
- Record id
cardio:ct-nct01508663- Content hash
a9ae07c11610cfc1d3ee294ec7ee4579513703933104b741339c08c2bd953222